ReviewFrontiers in pharmacology2025

Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways.

Shuwei Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.